Home › Lung Cancer › Connecticut › Hartford
Lung Cancer clinical trials in Hartford, CT
11 studies for Lung Cancer are looking for participants at sites in and around Hartford (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
RecruitingPhase 3
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
RecruitingPhase 3
- Hartford Hospital, Hartford
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi away
- and 1 more
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
RecruitingPhase 3
- Hartford Hospital, Hartford
- Hartford HealthCare - Avon, Avon · 8 mi away
- Hartford HealthCare - Manchester, Manchester · 8 mi away
- and 1 more
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RecruitingPhase 3
- Hartford Hospital, Hartford
Integrated Cancer Repository for Cancer Research
RecruitingObservational studyHealthy volunteers welcome
- Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester · 8 mi away
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
RecruitingPhase 2
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi away
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi away
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
RecruitingPhase 2/3
- Smilow Cancer Hospital Care Center at Saint Francis, Hartford
- Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi away
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
RecruitingPhase 1/2
- Hartford Hospital (site 210), Hartford
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Hartford
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier
RecruitingObservational study
- Trinity Health Of New England, Hartford
About Lung Cancer
Lung cancer forms in tissues of the lung, usually in the cells that line the air passages. It is the leading cause of cancer death in both men and women.
More about Lung Cancer on MedlinePlus
Lung Cancer trials in other cities
- Houston, TX78 studies
- Boston, MA62 studies
- New York City, NY60 studies
- Los Angeles, CA45 studies
- Arlington, VA41 studies
- Washington, DC41 studies
- Chicago, IL41 studies
- Nashville, TN40 studies
- Baltimore, MD40 studies
- St. Louis, MO39 studies
- Columbus, OH37 studies
- Philadelphia, PA36 studies
Other studies in Hartford
- Non-Small Cell Lung Cancer12 studies
- Major Depressive Disorder9 studies
- Cancer (all types)9 studies
- Breast Cancer9 studies
- Neuroblastoma8 studies
- Multiple Myeloma7 studies
- Pancreatic Cancer7 studies
- Prostate Cancer7 studies
- Ovarian Cancer7 studies
- Cardiovascular Disease7 studies
- Heart Failure7 studies
- Sickle Cell Disease5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.